Please assess the completion status of the following clinical trial:

Trial Title: Comparison of the Efficacy/Safety of Symbicort® Turbuhaler®,Seretide™ Diskus™ 50/500 µg & Terbutaline Turbuhaler® 0.4 mg

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Diagnosed with asthma since at least 6 months prior to first visit~* Prescribed daily use of glucocorticosteroids for at least 3 months prior to first visit~* At least one asthma exacerbation more than one but less than twelve months prior to first visit~Exclusion Criteria:~* Respiratory infection affecting asthma within 30 days before first visit~* Use of oral, rectal, or parenteral glucocorticosteroids for within 30 days before first visit~* Any significant disease or disorder that may jeopardize the safety of the patient~Additional inclusion and exclusion criteria will be evaluated by the Investigator.

- Gender: ALL
- Minimum Age: 12 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).